Mary Dwyer | Director
Kactus

Mary Dwyer, Director, Kactus

Mary Dwyer, PhD, is a scientific director with over 15 years of expertise in biologics drug discovery, specializing in antibody platforms and multi-specific formats. She has led groundbreaking initiatives, including establishing VHH discovery platforms and directing over 20 therapeutic antibody programs, two of which reached clinical trials. Her leadership spans immune-oncology and viral glycoprotein targets, pioneering novel screening techniques and integrating advanced technologies like Fc engineering. With a strong track record in team mentoring and project success, Mary has made significant contributions to biochemistry and immunology across roles at Eitr Biologics, AlivaMab Discovery Services, Abcore Inc., Celgene Inc., and currently Antharis

Appearances:



Festival of Biologics Day 2 @ 14:30

Engineering Complex Antigens for Biopharma Industry: Multipass Transmembrane Proteins

The presentation highlights KACTUS's mission to expedite drug development by providing high-quality biological reagents, including the largest collection of multipass transmembrane proteins. Innovative methods, such as detergent-free nanodisc preparation, ensure consistency and activity at lower costs. Case studies demonstrate the successful use of VLPs and nanodiscs in antibody discovery, driving advancements in biopharma research and securing multiple patents

Mary Dwyer, Director, Kactus
last published: 21/Mar/25 16:45 GMT

back to speakers